GHRL and scleroderma: A study on a mouse model showed that ghrelin prevents the development of dermal fibrosis through its antifibrotic action which suggests that ghrelin might be a candidate for research aiming to prepare a drug for the treatment of human scleroderma, a chronic inflammatory disease characterized by widespread fibrosis of the skin [292].